Get started
Sebas1231

$KBIO Long

Long
Sebas1231  
OTC:KBIO   None
PHARMA pharmaceuticals shkreli martinshkreli pharmastocks biotech biotechnology
2
0
pharma pharmaceuticals shkreli martinshkreli pharmastocks biotech biotechnology
12.5.2016- $KBIO currently trading at 4.25. Potential once they receive PRV (Priority Review Voucher) for Benznidazole possibility for trading at $5-6. Stock jumped about $1 due to the Letter to Stakeholders by Dr. Cameron Durrant. I expect this stock to rise.

Disclosure: I am long $KBIO

SEE MORE: globenewswire.com/ne...to-Stakeholders.html
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.